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Background: There have been a range of quality improvement (QI)
and quality assurance initiatives in low- and middle-income countries
to improve antiretroviral therapy (ART) treatment outcomes for people
living with HIV. To date, these initiatives have not been systematically
assessed and little is known about how effective, cost-effective, or
sustainable these strategies are in improving clinical outcomes.
Methods: We conducted a systematic review adhering to PRISMA
guidelines (PROSPERO ID: CRD42017071848), searching
PubMed, MEDLINE, Embase, Web of Science, and the Cochrane
database of controlled trials for articles reporting on the effectiveness
of QI and quality assurance initiatives in HIV programs in low- and
middle-income countries in relation to ART uptake, retention in care,
adherence, viral load suppression, mortality, and other outcomes
including cost-effectiveness and long-term sustainability.
Results: One thousand eight hundred sixty articles were found, of
which 29 were included. QI approaches were categorized as follows:
(1) health system approaches using QI methods; (2) QI learning
networks including collaboratives; (3) standard-based methods that
use QI tools to improve performance gaps; and (4) campaigns using
QI methods. The greatest improvements were seen in ART uptake
[median increase of 14.0%; interquartile range (IQR) 29.0 to 29.3],
adherence [median increase of 22.0% (IQR 27.0 to 25.0)], and viral
load suppression [median increase 26.0% (IQR 28.0 to 26.0)].
Conclusions: QI interventions can be effective in improving clinical
outcomes; however, there was signiﬁcant variability, making it
challenging to identify which aspects of interventions lead to clinical
improvements. Standardizing reporting and assessment of QI initia-
tives is needed, supported by national quality policies and directorates,
and robust research.
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INTRODUCTION
Considerable strides have been made in the scale-up of
antiretroviral therapy (ART) in low- and middle-income
countries (LMICs). By the end of 2017, 21.7 million people
living with HIV (PLHIV) were receiving ART, with a reported
fall of 48% in AIDS-related deaths since a peak in 2005.1,2
However, only 75% of the estimated 36.7 million PLHIV
globally know their status; 59% were receiving ART; and 47%
were virologically suppressed. In LMICs with the highest
burden of HIV, coordinated action is urgently needed to
achieve global targets, so 90% of all PLHIV know their status,
90% of those diagnosed as HIV positive start ART, and 90% of
all people receiving ART have durable viral suppression.3
There is increasing recognition of gaps along the cascade
of care and the need to strengthen the quality of service
delivery.4,5 Various quality improvement (QI) and quality
assurance (QA) strategies have been implemented in ART
programs.6,7 Many deﬁnitions of QI exist in the literature. The
recently published WHO National Quality and Policy Strategy
Manual (http://apps.who.int/iris/bitstream/handle/10665/
272357/9789241565561-eng.pdf?ua=1) deﬁnes QI as “a
change in process in a health-care system, service, or supplier
for the purposes of increasing the likelihood of optimal clinical
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quality of care measured by positive health outcomes for
individuals and populations.”8 For this review, we consulted
with the Quality of HIV Care Technical Working Group to
generate a narrower deﬁnition (Fig. 1): “a method of improving
program quality using standard QI methodologies involving
system analysis, process investigation and analysis of results/
indicators, developing solutions by teams, testing and measur-
ing effects of changes, and implementing and following up
improvement.” QA is deﬁned as “a process of external
measurement of performance against standards and expectation
that action will be taken to improve performance” (Fig. 1).
Across the global literature on QI initiatives globally, there
is a high risk of bias, with studies predominantly from high-
income countries or not speciﬁcally focused on HIV treatment
programs.9 Furthermore, the evidence base is limited by a lack
of systematic or robust examination of evidence on the
effectiveness of initiatives to improve quality in the delivery
of ART programs. As a result, there is a lack of consensus on
effective, cost-effective, or sustainable approaches.
We undertook a systematic review to identify and
synthesize evidence base on the cost-effectiveness, accept-
ability, impact of QI and QA initiatives on key clinical
outcomes in ART programs in LMICs, and wider indicators.
METHODS
This systematic review adhered to the Preferred Re-
porting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines,10 and the protocol published on the
PROSPERO database (CRD42017071848; https://www.crd.
york.ac.uk/prospero/display_record.php?RecordID=71848).
Inclusion and Exclusion Criteria
We included randomized controlled trials, observa-
tional studies, and gray literature reporting on the effective-
ness of QI and QA initiatives implemented in ART programs
in LMICs as deﬁned by the World Bank classiﬁcation.11
We considered evidence of effectiveness for predeﬁned
outcomes including:
• Key outcomes: ART uptake, retention in care, adherence,
viral load suppression, and mortality
• Other outcomes: uptake of screening, identiﬁcation, and
treatment of incident opportunistic infections, process
indicators such as CD4/VL testing, acceptability to patients
and/or service providers, and prevention of mother-to-child
HIV transmission
• Cost-effectiveness
• Wider impact (eg, long-term sustainability)
There were no restrictions on language. Research was
excluded if it was conducted in high-income countries, data for
key outcomes were not present, or the main focus of the
intervention was task-shifting, which is not considered a QI or
QA intervention for the purposes of this review. In addition,
articles only reporting on speciﬁc types of clinical care/
interventions (eg, prevention of mother-to-child HIV trans-
mission) were not included. These studies represent a sub-
stantial and important literature, and merit separate reviews
tailored to the speciﬁc methodologies and outcomes relevant to
these distinct areas. Training, clinical mentoring, and support-
ive supervision, without the precise improvement actions
deﬁned as part of QI, were not included because the focus
was on QI methods rather than the speciﬁc components of
interventions; in addition, we note that supportive supervision
and mentorship has its own literature, as part of broader QA
efforts. These decisions were made in consultation with the
Quality of HIV Care Technical Working Group.
Search Strategy
We searched the databases PubMed, MEDLINE,
Embase, Web of Science, and the Cochrane database of
FIGURE 1. Definitions and categorization of QI/QA interventions used for this systematic review.
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controlled trials from inception to October 24, 2017. We used
a Boolean search strategy with keywords relevant to QI, QA,
and HIV, identiﬁed from relevant research, previous related
systematic reviews, and consultation with the World Health
Organization and Quality of Clinical HIV Care Technical
Working Group (see Supplemental Digital Content, http://
links.lww.com/QAI/B330). Gray literature was obtained
through a hand-search of web search engines, related
websites, and submission by key experts in the Quality of
Clinical HIV Care Technical Working Group. These experts
were also formally invited to submit the gray literature
(conference abstracts, unpublished reports, presentations,
etc) relating to QI in ART programs in LMICs. The
bibliographies of included articles were cross-referenced,
and key experts consulted, to identify additional research.
Data Extraction and Analysis
Title and abstract screening was conducted by 3
reviewers (K.R., L.B.N., and S.H.). Subsequent full-text
screening was conducted by 2 reviewers (S.H. and K.R.).
Discrepancies were resolved through discussion with a third
reviewer. Screening was facilitated by the web-based appli-
cation Rayyan.12
Data were extracted by 2 reviewers (K.R. and S.H.)
using a piloted form on predeﬁned outcomes determined by
the study team through consultation with experts in the ﬁeld.
The outcomes included the following: ART uptake, retention
in care, adherence, viral load suppression, mortality, and other
wider outcomes (opportunistic infections, acceptability to
patients and service providers, process indicators, cost-
effectiveness, and long-term sustainability).
Quality and risk of bias were assessed by 2 reviewers
(K.B. and L.N.) using a piloted critical appraisal tool that
included indicators from the Joanna Briggs and
Newcastle–Ottawa scales as relevant for the diverse study
types.13,14 The average quality score was 69.1%. Quality
scores were divided into tertiles, categorizing articles in
relation to whether they were scored in the low
(22.7%–59.1%), medium (63.6%–72.7%), or high
(77.3%–100%) third of articles. Although study quality was
assessed to indicate methodological rigor and clarity and
transparency in reporting, studies were not excluded on the
basis of quality to strengthen the transparency of the review
and comprehensively report on all available evidence,
including both primary peer-reviewed research and the
gray literature.
All included studies were categorized in relation to
methodological approaches agreed in collaboration with the
identiﬁed panel of experts (Fig. 1): health system ap-
proaches using QI methods, standard-based methods that
use QI tools to improve performance gaps, campaigns that
use QI methods, and QI learning networks
including collaboratives.
Summary analyses were conducted in Microsoft Excel
and Stata 15 to show the distribution of percent increase
reported for each outcome by study and to calculate the
mean and median increase in the percentage of patients with
each clinical outcome to provide an indication of the
reported impact of QI interventions across the available
evidence base. We also compared the median increase in
ART uptake by methodological approach and country
setting and in programs focused on the prevention of
mother-to-child transmission (PMTCT) compared with the
general patient population. Where relevant data were not
reported for the predeﬁned outcomes, articles were not
included in the syntheses.
Role of the Funding Source
The funders of the study had no role in the study
design, data collection, data analysis, data interpretation,
writing of the report, or the decision to submit the article
for publication. All authors had full access to all data and
responsibility for the decision to submit for publication.
RESULTS
Overview of the Included Literature
A total of 1860 records were identiﬁed in the database
searches, with 1073 publications being subject to title and
abstract screening after removing duplicates. One hundred
one publications were carried forward for full-text screening,
in addition to 34 gray literature records. Of the 135 articles
included in the full-text screening, 29 were included in the
review (Fig. 2), including 14 peer-reviewed15–28 and 15 gray
literature articles (see Table 1, Supplemental Digital Content,
http://links.lww.com/QAI/B330).29–43 There was a signiﬁcant
variation in the quality of included studies (see Table 1,
Supplemental Digital Content, http://links.lww.com/QAI/
B330), with limited detail in relation to measures, outcomes
or deﬁnitions used, observational designs across most studies,
and a lack of data to isolate the effects of interventions.
Many initiatives involved a multifaceted package of
interventions. No studies were identiﬁed that reported solely
on QA; therefore, our results present no data on QA
initiatives. There are a range of quality initiatives being
evaluated in LMICs [Standards-based Management and
Recognition, HIVQUAL/HEALTHQUAL (Note HIVQUAL
changed its name to HEALTHQUAL), Breakthrough Series
Collaborative, and ASSIST], as well as multiple other
approaches (quality collaboratives, performance
management–QI, mentorship, and training without a speciﬁc
QI component, among others).
We grouped approaches into 4 main categories with
support from experts in the Quality of HIV Care Technical
Working Group (Fig. 1): health systems approaches using QI
methods (n = 20),21,22,24–26,29–43 standard-based methods that
use QI tools to improve performance gaps (n = 2),17,23
campaigns that use QI methods (n = 1),28 and QI learning
networks including collaboratives (n = 6).15,16,18–20,27 Initia-
tives were performed in 13 LMICs, including South Afri-
ca,15,19,20,28 Vietnam,16,35 Zambia,17,23 Nigeria,18,27
Uganda,21,22,31,36,40 Mozambique,21,22 Namibia,21,22,29,34,42,43
Haiti,21,22,24,32,36,41 Thailand,25,26 Nicaragua,33 Kenya,38 Tan-
zania,37 and Guyana,34,39 (Fig. 3). Across the studies, improve-
ments were reported for ART uptake (n = 17), ART adherence
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(n = 10), CD4 testing (n = 6), retention (n = 5), and cost (n = 1)
(Fig. 4).
Overall Impact of QI Approaches
There was signiﬁcant variation across the evidence
regarding the inﬂuence of QI initiatives on clinical outcomes
(Fig. 5). The greatest improvement was seen in ART uptake
median increase of 14.0%; interquartile range (IQR) 29.0 to
29.3 of patients across sites], ART adherence [median
increase of 22.0% (IQR 27.0 to 25.0)], and viral load
suppression [median increase 26.0% (IQR 28.0 to 26.0)]
(see Table 1, Supplemental Digital Content, http://links.lww.
com/QAI/B330).
These outcomes should be considered in the context of
other initiatives and national policy and program changes that
may have targeted ART uptake and adherence, and viral load
suppression at the same time. Improvements may also be
partly attributed to inclusion of programs focused on the
prevention of mother-to-child transmission (PMTCT; see
Table 1, Supplemental Digital Content, http://links.lww.
com/QAI/B330). We conducted a sensitivity analysis to
examine the increase in ART uptake in pregnant women
compared with the general patient population across the
FIGURE 2. PRISMA flow diagram.
FIGURE 3. Proportion of QI initiatives re-
ported in the included literature.
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evidence, identifying that the median percentage increase in
patients initiating ART in programs focused on PMTCT was
19.0% (IQR 13.5–40.5) compared with 13.0% (IQR
4.5–29.3) for programs directed at the general population
(Table 1), although this was not statistically signiﬁcant.
There was also signiﬁcant variation in the effectiveness
of QI interventions across initiatives implemented in different
country settings. The highest median percentage improve-
ment in ART uptake was seen in Vietnam (29.0%, IQR
29.0–29.5), followed by Haiti (25.0%, IQR 13.0–37.0);
however, there were limited data for other countries and
variability in the length of follow-up, making it challenging to
make meaningful cross-country comparisons (Table 2). For
example, 3 studies looking to improve ART uptake had
follow-up periods of 8,35 12,31 and 24 months.32
Effectiveness by QI Methodological Approach
Health System Approaches Using QI Methods
Twenty studies (5 published and 15 gray literature)
were categorized as health system approaches using QI
methods (eg, including systems analysis, process investiga-
tion and analysis of results/indicators, developing solutions
by teams, testing and measuring effects of changes, and
implementing and following up improvement) (Fig. 1).
Fourteen studies reported outcomes related to ART uptake,
generally showing a positive impact. In 1 study, the number
of eligible children taking up treatment rose from 12% to
25%,32 whereas ART uptake rose from 61% to 90% in
another health system intervention.35 Even in a previously
well-performing setting, ART uptake rose from 98% to 100%
after the introduction of the intervention.25 However, there
were also 2 examples of a decline in ART uptake. In one such
case, uptake fell from 82% to 76% over a 12-month period,31
whereas in another, CD4 testing for subsequent ART
treatment in individuals with CD4 cell counts ,200/mL
dropped from 100% to 90% of eligible individuals.26 Overall,
the median percentage increase in patients initiated on ART in
programs using this methodological approach was 13.0%
(IQR 5.5–34.3), with a range of 213.0% (decrease) to 59.0%
(Table 1).
Among articles reporting health system approaches
using QI methods, there were also 9 studies reporting ART
adherence (2 published and 7 gray literature) and 5 studies
reporting on retention. Six of the 9 studies reporting
adherence outcomes showed improved adherence documen-
tation and recording procedures, as opposed to being related
directly to the level of adherence seen in individuals on
treatment. One study reported that pediatric adherence rose
from 43% to 81%,36 whereas a multicenter study documented
improvements in adherence from 90% to 97% in Namibia,
63%–85% in Uganda, 66%–97% in Mozambique, 29%–83%
in Haiti, and 56%–80% in Guyana.39 One study reported
a decrease in adherence from 82% to 76%; however, this
ﬁnding may be due to an associated improvement in
documentation procedures and adherence assessment, which
increased from 81% to 92%.31 Retention was also suggested
to slightly increase across the studies (median increase 3.0%,
IQR 3.0–3.0; range 3.0–25.0).
Health system approaches using QI methods were also
associated with positive impacts on process indicators. CD4
testing rates over 6 months improved from 43% to 78% in 1
setting35 and from 10.8% to 20.5% when testing individuals
on enrollment and after 6 months of follow-up.41 However,
there were not always substantial gains or improvements.25
Prophylaxis access for opportunistic infections also increased.
One study reported an increase from 12% to 95% of children
receiving cotrimoxazole prophylaxis,43 whereas another re-
ported that prophylaxis peaked during the intervention at
84.8% of eligible individuals receiving treatment.41 Tubercu-
losis screening also increased across all reports, with 1
example citing an increase from 24% to 99%.26
QI Learning Networks Across Multiple Sites
(Including Collaboratives)
Six peer-reviewed articles reported on QI learning
networks (including collaboratives), which included coach-
ing and mentoring of health care staff, alongside peer
exchange to address performance gaps. One model adopted
was the Breakthrough Series (BTS) collaborative,15 which
brings facility teams together to learn QI methods, identify
performance gaps, and plan implementation interventions,
with follow-up visits from quality mentors to coach teams
on using QI methods and maintain momentum for improve-
ment. Four studies reported on ART uptake outcomes, all of
which showed improvements. Overall, the median increase
in ART uptake was 22.0% (IQR 12.8–29.8) (Table 1). One
study reported a district level increased uptake of 62%–91%
FIGURE 4. Proportion of included studies re-
porting improvements in key outcomes.
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over 30 days.16 In another setting, monthly ART initiation
rose 185.5% after initiation of the intervention, from 179
initiations per month to 511.19 ART adherence and reten-
tion were only reported in 1 study each. The study that
included adherence outcomes reported improvements in
documentation of adherence support and adherence assess-
ment procedures, and it was not clear if there was an impact
on patient adherence. In this study, documentation
improved from 83% to 99% at the provincial level and
from 54% to 97% at the district level.16 In terms of ART
retention, the 1 reporting study found no impact associated
with the intervention, with no statistically signiﬁcant
difference in retention of postpartum women after 6 months
in the intervention and control arms.18
The effects of QI interventions on process indicators,
opportunistic infection, and TB screening were sparsely
reported. The studies reporting on process indicators indi-
cated an improvement associated with the intervention. CD4
testing in the previous 6 months increased from 80% to 94%
at the provincial level and from 72% to 74% at the district
level in 1 setting,16 and rates of early infant testing at 4–6
weeks increased in intervention sites from 25.3% to 48.8% in
another study.18 Data quality was reported to have improved
in another setting.27 Cotrimoxazole prophylaxis prescription
to combat opportunistic infections in eligible individuals
increased in one study from 31% to 99% at the provincial
level and from 75% to 83% at the district level, whereas TB
screening in this same study also increased from 15% to
FIGURE 5. Median percentage increase in out-
comes across QI/QA initiatives.
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100% at the provincial level and from 18% to 79% at the
district level.16
One study further looked at the acceptability of the
intervention to health care workers and patients. However,
despite enthusiastic participation in the program by health
care workers, there was no measurable increase in patient
satisfaction.27
Standard-Based Methods that Use QI Tools to
Improve Performance Gaps
The 2 citations that used standard-based methods only
reported on acceptability of the intervention (2 published and
0 gray literature).17,23 The studies initially sought to deﬁne
performance criteria relevant to the context, before using
outside support to measure pre-existing performance gaps (in
relation to the new standards), which are subsequently
addressed and reassessed. In both studies, the authors
indicated that health care worker perceptions of their work
environment were positively impacted by the intervention,
whereas they declined in comparison sites. Standard-based
methods also increased ART readiness scores and provider
performance related to ART and PMTCT at the intervention
sites versus comparison sites.17
Campaigns That Use QI Methods
Only 1 study reported a QI campaign among health
workers (Fig. 1) in 2 districts in KwaZulu-Natal, South
Africa, between 2009 and 2010, and was included as
a separate category on consultation with the expert group.28
This study reported on outcomes related to ART uptake
among HIV-infected pregnant women and cost, ﬁnding that
monthly referrals for ART rose from 78.7 [95% conﬁdence
interval (CI): 69 to 89] individuals to 188.2 (95% CI: 167 to
209), whilst monthly ART initiation concurrently rose from
20.7 (95% CI: 2 to 40) individuals to 123.8 (95% CI: 108 to
140), with much smaller increases in the control district
(39–55 initiations per month). In terms of cost, there was no
formal analysis; however, the authors state that they believed
the interventions could be rapidly implemented with a low
incremental cost because no new personnel were added to the
existing health system.
DISCUSSION
This is the ﬁrst systematic review to explore the
evidence base on the effectiveness of interventions to
improve quality in ART programs in LMICs and to deﬁne
and categorize methodological approaches being imple-
mented in these settings. The review suggests that QI
initiatives at a site level, applied at multisite learning
collaboratives, and as part of a campaign, were associated
with increased ART uptake and ART adherence across
sites. However, there was variability in the effect across
studies and approaches. Although the ﬁndings point to the
potential effectiveness of QI interventions to improve
quality, we should interpret the results with caution given
the limitations of the study designs; ie, lack of comparators
or the contribution of other initiatives. This points to the
need for more rigorous evaluation methods to assess the
impact of QI interventions and innovative approaches to
assessing quality in public health initiatives more broadly.
It is also important to be aware of a bias toward publication
of positive results.
The effect of other program factors is noted in some
cases, both in rapid improvement of clinical outcomes and in
an apparent worsening of outcomes in some cases, which
could inﬂuence the interpretation of QI studies. For exam-
ple, in Uganda, ART uptake decreased from 82% to 76%
over 12 months,31 and in Thailand, CD4 testing coverage
dropped from 100% to 90%.26 Because both of these studies
were supported by authors of this article, further information
was obtained from the program reports, and it is reported
that in subsequent years, ART coverage increased, whereas
the number of patients enrolled in care increased dramati-
cally over that time period. As well, in Thailand, the drop in
CD4 monitoring may have been related to a rapid expansion
in the program from 12 hospitals in 2002 to 64 in 2006, thus
highlighting the impact of other program factors. The
heterogeneity across QI initiatives makes it challenging to
discern the relative beneﬁt of speciﬁc QI approaches. Both
increases and decreases in outcomes need to be contextual-
ized in relation to factors such as methodological variations,
socioeconomic conditions, changes in health expenditure,
and other possible factors such as stock-outs and
documentation challenges.
Our ﬁndings concur with a recent systematic review
exploring the QI collaborative approach mostly being eval-
uated in high-income countries, which reported that the
evidence for effectiveness of initiatives that use QI collabo-
ratives is positive, but that the effects cannot be predicted
with great certainty with limited evidence of effectiveness,
cost-effectiveness, and sustainability.7
Many QI initiatives involve a complex multifaceted
package of interventions. For example, HEALTHQUAL is
a public health model for capacity building and can involve
multiple interventions as part of the effort to improve health
systems. Studies may also report outcomes on initiatives
involving QI and other capacity-building initiatives and also
adapt established QI models to local use.16 This means that it
is often not straightforward to identify which particular aspect
of a QI initiative has led to improvements. While QI
initiatives target multiple health systems components of
clinical processes, it is challenging to identify which factors
contribute to improvements, because other national initiatives
may be introduced simultaneously making it challenging to
identify which factors contribute to improvements. “However
TABLE 1. Changes in ART Uptake by Population and QI/QA
Approach
Population QI Approach
Maternity General
Health System
Approach Using
QI Methods
QI Learning
Network
Mean % (SD) 28.0 (17.6) 19.0 (20.0) 20.0 (21.3) 23.0 (12.0)
Median % (range) 19.0
(12.0 to 56.0)
13.0
(213.0 to 59.0)
13.0
(213.0 to 59.0)
22.0
(12.0 to 41.0)
IQR 25%–75% 13.5 to 40.5 4.5 to 29.3 5.5 to 34.3 12.8 to 29.8
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it is hypothesized that this more holistic approach required...”
if possible to rephrase think would be better to say “It has
been suggested that QI initiatives and methods should be
judged on the overall effectiveness of the program,” rather
than attempting to elucidate which speciﬁc components are
most integral to the beneﬁts observed.44
Strengths and Limitations
The review used a rigorous approach, aligning with
PRISMA guidelines and was registered prospectively in
PROSPERO. The results are driven by a comprehensive
search strategy, which includes 5 databases and gray
literature. The assessment of key clinical outcomes
alongside other wider effects allowed for a broad exam-
ination of evidence of effectiveness, enabling a robust
synthesis to evaluate and inform QI initiatives. A formal
meta-analysis was not deemed appropriate given the
heterogeneity in QI approaches, study methods, and
reporting. However, studies consistently reported percent
increases in the predeﬁned outcomes, allowing such data
to be combined and summarized to provide an indication
of the reported impact of QI interventions across the
available evidence base.
The signiﬁcant variation in the quality of study designs
as well as reported outcomes and their deﬁnitions highlights
the need to improve methodological rigor in evaluation and
research in this area. The evidence base would be strength-
ened by efforts to adopt emerging QI evaluation designs.45
The decision to retain articles and not exclude on the basis of
quality was essential to demonstrate the range of quality
across the available evidence base and the need to strengthen
study quality, beneﬁtting the transparency and impact of
this review.
There was limited reporting of QI initiatives in both the
published and gray literature, with few peer-reviewed studies
of the effectiveness of QI/QA initiatives, or publicly available
evaluations. For many organizations, QI is part of standard
technical assistance for countries, and reports of QI work may
be disseminated only internally within the support organiza-
tions or funding bodies.
Another key limitation is that improvements may not be
solely attributed to the QI interventions but also to wider
initiatives targeting HIV programs or health care systems, or
improvements in documentation and data recording proce-
dures. For example, changes in national policies to shift CD4
eligibility criteria or HIV testing campaign or expansion of
sites/task-shifting/decentralization effort would improve cer-
tain outcomes unrelated to the speciﬁc QI efforts. Future
research should aim to address these concerns, and where
interventions are implemented, these wider contextual factors
should be acknowledged through the adoption of implemen-
tation science frameworks.
The WHO recently published recommendations for
standard program reporting standards,46 standards for
sexual and reproductive health, which could be enhanced
with practitioners agreeing on a common set of clinical and
health system outcomes. It has also been proposed that the
design and evaluation of such programs should be
mutually informing for both improvers and evaluators.
The Framework for Learning about Improvement and the
Evaluation Continuum, for example, provides a structure
to improve the design, implementation, and evaluation of
improvement programs. This could enable both the
generation of more robust and generalizabile data and
improve understandings of the mechanisms contributing to
improvement and how to scale-up improvement efforts.47
Evaluation of programmatic quality could be further
enhanced through improved reporting mechanisms to assess
implementation, which could be based on commonly agreed
core components for QI programs.48 Standardized quality
scores based on national guidelines for care recommendations
have been developed in similar contexts assessing adherence
to such guidelines and have been shown to be associated with
decreased mortality in these settings.49 The implementation of
such procedures across all settings would enable a fuller
comparison of QI programs, alongside their respective stand-
ards of quality both before and after intervention.48
The ability to assess the impact of QI interventions on
clinical outcomes or determine which speciﬁc approaches
result in the greatest improvements is also limited by
observational study designs. However, a key strength of the
approaches across the included studies is the development
and implementation of interventions in the incorporating local
context at which they are aimed, which is likely to increase
the success of QI initiatives.44
Most of the included studies had externally funded
implementing partners providing staff to support data collec-
tion, implementation, and evaluation. This reliance on
external technical support raises a question about the
sustainability and scalability of these interventions. Many
interventions included participation from management and
frontline teams of the local health system but did not
demonstrate the ability to undertake QI efforts using local
data systems, or sustainability or scalability beyond the life of
the project.
The use of external or parallel data systems also
circumvented the poor quality of routinely collected data—
a major obstacle to the implementation, scale-up, sustainabil-
ity, and evaluation of QI interventions. Many of the studies
reported in the review used data that were collected
independently of the local routine data reporting systems,
TABLE 2. Changes in ART Uptake by Country of Study
South Africa Vietnam Haiti Thailand Namibia Uganda Mozambique Guyana
Mean % (SD) 23.0 (14.1) 29.0 (0.6) 26.0 (14.5) 2.0 22.0 (923.4) 18.0 (28.4) 213.0 5.0
Median % (range) 14.0 (12.0–41.0) 29.0 (29.0–30.0) 25.0 (13.0–40.0) 2.0 15.0 (3.0–56.0) 9.5 (26.0 to 59.0) 213.0 5.0
IQR 25%–75% 12.0–21.5 29.0–29.5 13.0–37.0 — 9.0–28.3 3.75 to 23.8 — —
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and the future performance of those initiatives may be
dependent on continued support. There are some examples
of large scale QI programming that used routine data systems,
showing that is possible to improve local data systems to the
point where they can be used for QI approaches. Although
one of the aims of this review was to assess sustainability, the
identiﬁed literature did not speciﬁcally address this question,
so no data are presented.
Conclusions and Further Research
Our ﬁndings support the effectiveness of QI in ART
programs, with the greatest improvement in clinical outcomes
seen in ART uptake, adherence, and viral load suppression,
and in programs focused on PMTCT. Although the evidence
suggests QI initiatives are associated with improved clinical
outcomes, there was signiﬁcant heterogeneity across ap-
proaches, settings, and reporting, making it challenging to
identify best practices and to understand what speciﬁc aspects
of these interventions lead to signiﬁcant and sustainable
clinical improvements in an LMIC context. Furthermore,
there was very limited evidence on the cost-effectiveness of
these interventions and a need for formal economic analyses
to determine the cost implications of QI initiatives.
The ﬁndings point to the need to better use standard
evaluation designs and reporting methods.46,50 Although
programmatic quality reporting focusing on the implementa-
tion of interventions against established guidelines would
enhance our ability to compare the effectiveness of inter-
ventions across diverse settings, it could also be tailored the
speciﬁc context in which programs are being delivered, for
example, primary health care sites as opposed to specialty
care.5,48,49,51
A further key consideration for practice is the need to
embed QI initiatives within national efforts to improve health
systems. Most of the studies in this review were supported or
conducted by implementing partners with external funding,
using external data collection and analysis systems. The
question remains what approaches will be needed to support
the capacity of health systems in LMICs to undertake these
approaches through their existing quality management infra-
structure without a need for external partners and funding. In
a related ﬁeld, the WHO-led Network for Improving Quality
of Care for Maternal Newborn and Child Health Care is
driving the approach of moving care away from NGO-led,
fragmented, and often unsustainable individual QI projects
toward country-led initiatives.52 WHO is also providing
guidance to governments on how to design and organize
national QI programming through development of their
national quality policy and strategies, an approach that
supports embedding QI in ART programmes within the
context of a national quality policy and strategy in support
of broader universal health coverage goals53,54 across HIV
programs globally.52
Research is needed to evaluate the effectiveness, cost-
effectiveness, and long-term sustainability of QI interventions
and to identify which elements contribute to improved clinical
outcomes in LMICs. This will support efforts to achieve the
90-90-90 goals55 and aligns with the recent Lancet Global
Health Commission on High-Quality Health in the SDG
Era.56 Ultimately, evidence-based QI methods must be
integrated into broader efforts to ensure the delivery of
high-quality care in low resource settings, within the context
of the WHO Framework on integrated people-centered health
services.57,58
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